Global Plasma Fractionation Market Analysis, Trends and Forecast by 2023 - Market Research Report 2018

According to Stratistics MRC, the Global Plasma Fractionation Market is accounted for $18.14 billion in 2016 and is expected to reach $30.14 billion by 2023 growing at a CAGR of 7.5% during the forecast period. Factors such as rising geriatric population and increasing number of hemophilic patients are boosting the market growth. On the contrary, strict government rules, huge cost and limited reimbursements are some of the factors hampering the market. Rising digit of hemophilic patients is creating growth opportunities for vendors in the market.

Browse The Report: http://orbisresearch.com/reports/index/plasma-fractionation-global-market-outlook-2017-2023

By product, immunoglobulin segment witnessed the largest market share during the forecast period. However, protease inhibitors segment is expected to witness the fastest growth rate in the next five years. The growth of this segment is mainly attributed to its increasing use for respiratory diseases and growing application in various diseases.

By region, North America accounted for largest market share followed by Europe due to increasing use of immunoglobulins in neurological diseases and increasing use of prophylaxis treatments for diagnosed patients, and the rising number of registered hemophilic patients in this region.

Some of the key players in global plasma fractionation market include Octapharma AG, Chinese Biological Products, Inc., Bio Products Laboratory, Baxter International, Inc., Csl, Ltd., Grifols International SA, Shanghai Raas Blood Products Co., Ltd, China Biologic Products, Inc., Biotest, Kedrion S.P.A., LFB SA and Sanquin.

Request a Free Sample of The Report: http://orbisresearch.com/contacts/request-sample/2028287

Products Covered:
Protease Inhibitors
Coagulation Factor Concentrates
Immunoglobulin
Fractionation Process
Albumin
Other Plasma Products

End Users Covered:
Clinical Research Laboratories
Academic Institutes
Hospitals and Clinics

Applications Covered:
Rheumatology
Pulmonology
Hemato-Oncology
Immunology
Neurology
Critical Care
Hematology
Other Applications

Regions Covered:
North America
US
Canada
Mexico
Europe
Germany
France
Italy
UK
Spain
Rest of Europe
Asia Pacific
Japan
China
India
Australia
New Zealand
Rest of Asia Pacific
South America
Argentina
Brazil
Chile
Rest of South America
Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Major Points From The Table Of Contents:

Executive Summary
Preface
Market Trend Analysis
Porters Five Force Analysis
Global Plasma Fractionation Market, By Product
Global Plasma Fractionation Market, By End User
Global Plasma Fractionation Market, By Application
Global Plasma Fractionation Market, By Geography
Key Developments
Company Profiling

About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Information:
Hector Costello          
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +9164101019
Email: sales@orbisresearch.com